iWalk, the Cambridge, MA-based developer of an actively powered prosthetic ankle and foot, has raised a new round of venture financing that provides a post-money valuation of $20 million, according to Rick Casler, the company’s chief technology officer. The amount of equity investment isn’t yet being disclosed, although General Catalyst led the round, Casler says, and WFD Ventures has a seat on the board, according to a regulatory filing. iWalk, founded in 2006, is a spinoff from MIT’s Media Lab.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
